Biomedical Sciences

Biomedical Sciences Experts

Joann Scatina

Senior Vice President
Biomedical Sciences
United States of America


    Dr. JoAnn Scatina joined Lycera in 2011 and brings more than 20 years of experience in preclinical development, most recently as vice president of drug metabolism at Wyeth Research. Dr. Scatina has extensive and broad experience in the evaluation of drug metabolism and pharmacokinetic properties of drug candidates from all therapeutic areas, from the discovery phase through global registration. At Wyeth, she led a team of up to 100 scientists, responsible for the preclinical development of marketed products including Premarin®, Duract®, Lodine®, Sonata®, Effexor®, Pristiq® and Rapamune® (1985 to 2001). Recently marketed and late stage products supported (2001 to 2010) include Tygacil®, Mylotarg®, Relistor®, Viviant®, Vabicaserin® and Neratinib®. Under Dr. Scatina’s entrepreneurial leadership, the Drug Metabolism department spearheaded numerous cutting edge strategies and technologies earning both corporate recognition and external visibility, with more than 80 publications, presentations and patents in 2008. Her most recent achievements include the establishment of a more efficient organizational model for discovery support, as well as the design of strategies to provide rapid improvement in compound properties that contributed to the successful progress of 12 to 16 development track compounds annually from 2001 to 2008  

Research Interest

 Diagnostic Techniques and Biomedical Analysis Biomedicine

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences